Search
for
Sort by
Research 661–690 of 922
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- Female pattern hair loss: current treatment concepts.
- Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
- Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women
- 5α-Reduced glucocorticoids: a story of natural selection
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review
- Hormonal Contraceptives and Dermatology
- Female pattern alopecia: current perspectives
- Prospective Cohort Study on the Effects and Tolerability of Flutamide in Patients with Female Pattern Hair Loss
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis
- Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement
- Polycystic ovary syndrome and its management: In view of oxidative stress
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
- The Mechanism of Androgen Actions in PCOS Etiology
- Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries
- Current evaluation of amenorrhea
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Hirsutism: diagnosis and treatment
- A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence